Adenosine in cold blood cardioplegia-a placebo-controlled study

Interactive Cardiovascular and Thoracic Surgery

Volumn 14, Issue 1, 2012, Pages 48-55

  Ahlsson, Anders ^a   Sobrosa, Claudio ^a   Kaijser, Lennart ^b   Jansson, Eva ^b   Bomfim, Vollmer ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Circulatory haemodynamics; Coronary sinus; Myocardial biopsy; Myocardial metabolism; Myocardial protection

Indexed keywords

ADENOSINE; CREATINE KINASE MB; LACTIC ACID; NUCLEOTIDE; OXYGEN; PLACEBO; TROPONIN T; ADENINE NUCLEOTIDE; VASODILATOR AGENT;

AGED; ANALYSIS OF VARIANCE; ANTEGRADE CARDIOPLEGIA; AORTA OCCLUSION; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; COLD BLOOD CARDIOPLEGIA; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOUBLE BLIND PROCEDURE; ENZYME RELEASE; FEMALE; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART PROTECTION; HEMODYNAMICS; HUMAN; HUMAN TISSUE; HYPERTENSION; LEFT VENTRICULAR STROKE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROGRADE CARDIOPLEGIA; TISSUE LEVEL; BIOPSY; CLINICAL TRIAL; COLD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; HEART ARREST; HEART VALVE REPLACEMENT; METABOLISM; METHODOLOGY; PEROPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ADENINE NUCLEOTIDES; ADENOSINE; AGED; BIOPSY; COLD TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART ARREST, INDUCED; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRAOPERATIVE COMPLICATIONS; LACTIC ACID; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84861317286     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivr027     Document Type: Article

References (22)

1. Doenst T, Bugger H, Schwarzer M, Faerber G, Borger MA, Mohr FW. Three good reasons for heart surgeons to understand cardiac metabolism. Eur J Cardiothorac Surg 2008;33:862-71.
2. Hudspeth DA, Nakanishi K, Vinten-Johansen J, Zhao ZQ, McGee DS, Williams MW, Hammon JW Jr. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann Thorac Surg 1994;58:1637-44.
3. Vinten-Johansen J, Zhao ZQ, Corvera JS, Morris CD, Budde JM, Thourani VH et al. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery. Ann Thorac Surg 2003;75:S691-9.
4. Bolling SF, Childs KF, Ning XH. Adenosine's effect on myocardial functional recovery: substrate or signal? J Surg Res 1994;57:591-5.
5. Belhomme D, Peynet J, Florens E, Tibourtine O, Kitakaze M, Menasche P. Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann Thorac Surg 2000;70:590-4.
6. Cohen G, Feder-Elituv R, Iazetta J, Bunting P, Mallidi H, Bozinovski J et al. Phase 2 studies of adenosine cardioplegia. Circulation 1998;98: II225-33.
7. Liu R, Xing J, Miao N, Li W, Liu W, Lai YQ et al. The myocardial protective effect of adenosine as an adjunct to intermittent blood cardioplegia during open heart surgery. Eur J Cardiothorac Surg 2009;36:1018-23.
8. Mentzer RM Jr., Birjiniuk V, Khuri S, Lowe JE, Rahko PS, Weisel RD et al. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 1999;229:643-9. discussion 649-650.
9. Rinne T, Laurikka J, Penttila I, Kaukinen S. Adenosine with cold blood cardioplegia during coronary revascularization. J Cardiothorac Vasc Anesth 2000;14:18-20.
10. Shalaby A, Rinne T, Jarvinen O, Saraste A, Laurikka J, Porkkala H et al. Initial results of a clinical study: adenosine enhanced cardioprotection and its effect on cardiomyocytes apoptosis during coronary artery bypass grafting. Eur J Cardiothorac Surg 2008;33:639-44.
11. Cohen G, Shirai T, Weisel RD, Rao V, Merante F, Tumiati LC et al. Optimal myocardial preconditioning in humans. Ann NY Acad Sci 1999; 874:306-19.
12. Mentzer RM Jr., Rahko PS, Molina-Viamonte V, Canver CC, Chopra PS, Love RB et al. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol 1997;79:38-43.
13. Carrier M, Pelletier LC, Searle NR. Does retrograde administration of blood cardioplegia improve myocardial protection during first operation for coronary artery bypass grafting? Ann Thorac Surg 1997;64:1256-61.
14. Kaukoranta PK, Lepojarvi MV, Kiviluoma KT, Ylitalo KV, Peuhkurinen KJ. Myocardial protection during antegrade versus retrograde cardioplegia. Ann Thorac Surg 1998;66:755-61.
15. Lotto AA, Ascione R, Caputo M, Bryan AJ, Angelini GD, Suleiman MS. Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery. Ann Thorac Surg 2003; 76:1227-33.
16. Norman B, Sabina RL, Jansson E. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. J Appl Physiol 2001;91:258-64.
17. Jin ZX, Zhou JJ, Xin M, Peng DR, Wang XM, Bi SH et al. Postconditioning the human heart with adenosine in heart valve replacement surgery. Ann Thorac Surg 2007;83:2066-72.
18. Lee HT, LaFaro RJ, Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 1995;10:665-76.
19. Wei M, Kuukasjarvi P, Laurikka J, Honkonen EL, Kaukinen S, Laine S et al. Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting. Chest 2001;120:860-5.
20. Ruengsakulrach P, Buxton BF. Anatomic and hemodynamic considerations influencing the efficiency of retrograde cardioplegia. Ann Thorac Surg 2001;71:1389-95.
21. Yau TM, Ikonomidis JS, Weisel RD, Mickle DA, Hayashida N, Ivanov J et al. Which techniques of cardioplegia prevent ischemia? Ann Thorac Surg 1993;56:1020-8.
22. Bomfim V. Myocardial protection during aortic valve replacement: a clinical and laboratory study of intra-operative myocardial metabolism. Scand J Thorac Cardio Vasc Surg Suppl 1981;29:1-26.